Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 25303 

class(es) of controlled substance(s). 

Refer to Supplemental Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before May 31, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 31, 2022. 

ADDRESSES: The Drug Enforcement 

Administration (DEA) requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 21, 2022, 

Purisys, LLC, 1550 Olympic Drive, 

Athens, Georgia 30601–1602, applied to 

be registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana Extract .......... 7350 I 

Marihuana ....................... 7360 I 

Tetrahydrocannabinols ... 7370 I 

Nabilone ......................... 7379 II 

Phenylacetone ................ 8501 II 

Levorphanol .................... 9220 II 

Thebaine ......................... 9333 II 

Opium, Raw .................... 9600 II 

Opium, Power ................. 9639 II 

Opium Granulated .......... 9640 II 

Noroxymorphone ............ 9668 II 

Controlled substance Drug 

code Schedule 

Concentrate of Poppy 

Straw.

9670 II 

Tapentadol ...................... 9780 II 

The company plans to import Opium, 

Raw (9600), Opium, Powered (9639) and 

Opium, Granulated (9640) to 

manufacture Active Pharmaceutical 

Ingredient (API) only for distribution to 

its customers. The company plans to 

import Phenylacetone (8501) and Poppy 

Straw Concentrate (9670), to bulk 

manufacture other controlled substances 

for distribution to its customers. The 

company plans to import impurities of 

buprenorphine that have been 

determined by DEA to be captured 

under Thebaine (9333). In reference to 

Marihuana (7360) and 

Tetrahydrocannabinols (7370) the 

company plans to import as synthetic. 

No other activity for these drug codes is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–09034 Filed 4–27–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–993] 

Importer of Controlled Substances 

Application: SpecGX LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: SpecGX, LLC has applied to 

be registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplemental Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before May 31, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 31, 2022. 

ADDRESSES: The Drug Enforcement 

Administration (DEA) requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 26, 2022, 

SpecGX LLC, 3600 North 2nd Street, 

Saint Louis, Missouri 63147, applied to 

be registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled 

substance 

Drug 

code Schedule 

Marihuana ....................... 7360 I 

Phenylacetone ................ 8501 II 

Coca Leaves .................. 9040 II 

Thebaine ......................... 9333 II 

Opium, Raw .................... 9600 II 

Poppy Straw Concentrate.9670 II 

Tapentadol ...................... 9780 II 

The company plans to import the 

listed controlled substances for bulk 

manufacture into Active Pharmaceutical 

Ingredients (API) for distribution to its 

customers. In reference to Tapentadol 

(9780) and Thebaine (9333), the 

company plans to import intermediate 

forms of these controlled substances for 

further manufacturing prior to 

distribution to its customers. In 

reference to drug code 7360 

(Marihuana), the company plans to 

import synthetic cannabinol. No other 

activity for this drug is authorized for 

this registration. Placement of these 

codes onto the company’s registration 


jspears on DSK121TN23PROD with NOTICES1
25304 Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 

does not translate into automatic 

approval of subsequent permit 

applications to import controlled 

substances. Approval of permit 

applications will occur only when the 

registrant’s business activity is 

consistent with what is authorized 

under 21 U.S.C. 952(a)(2). Authorization 

will not extend to the import of Food 

and Drug Administration-approved or 

non-approved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–09033 Filed 4–27–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–997] 

Bulk Manufacturer of Controlled 

Substances Application: Sterling 

Wisconsin, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sterling Wisconsin, LLC, has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before June 27, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before June 27, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on February 28, 2022, 

Sterling Wisconsin, LLC, W130N10497 

Washington Drive, Germantown, 

Wisconsin 53022–4448, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Lysergic acid 

diethylamide.

7315 I 

Marihuana Extract ........... 7350 I 

Marihuana ........................ 7360 I 

Tetrahydrocannabinols .... 7370 I 

Mescaline ........................ 7381 I 

5-Methoxy-N-NDimethyltryptamine.7431 I 

Psilocybin ........................ 7437 I 

Oliceridine ........................ 9245 II 

Thebaine .......................... 9333 II 

Alfentanil .......................... 9737 II 

The company plans to bulk 

manufacture the listed controlled 

substances to be commercially sold to 

registered manufacturers/suppliers. In 

reference to drug codes 7350 

(Marihuana Extract), 7360 (Marihuana), 

and 7370 (Tetrahydrocannabinols), the 

company plans to bulk manufacture 

these drugs as synthetic. No other 

activities for these drug codes are 

authorized for this registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–09060 Filed 4–27–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–994] 

Bulk Manufacturer of Controlled 

Substances Application: Research 

Triangle Institute 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Research Triangle Institute 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before June 27, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before June 27, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on March 11, 2022, 

Research Triangle Institute, 3040 East 

Cornwallis Road Hermann Building, 

Room 106, Research Triangle Park, 

North Carolina 27709, applied to be 

registered as a bulk manufacturer of the 

following basic class of controlled 

substance: 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols ... 7370 I 

The company plans to bulk 

manufacture the listed controlled 

substance synthetically only for 

distribution to its customers for research 

and analytical reference standards. No 

other activities for this drug code are 

authorized for this registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–09056 Filed 4–27–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Agency Information Collection 

Activities; Comment Request 

ACTION: Notice. 

SUMMARY: The Department of Labor’s 

(DOL’s) Employment and Training 

Administration (ETA) is soliciting 

comments concerning a proposed 

revision to the authority to conduct an 

information collection request (ICR) 

titled, ‘‘ETA Financial Report Form 

ETA–9130.’’ This comment request is 

part of DOL’s continuing efforts to 

reduce respondent burden in accord 


jspears on DSK121TN23PROD with NOTICES1